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Abstract
Objective Implantable cardioverter defibrillators (ICD) and
cardiac resynchronisation therapy (CRT) have substantially
improved the survival of patients with cardiomyopathy. Eligi-
bility for this therapy requires a left ventricular ejection frac-
tion (LVEF) <35 %. This is largely based on studies using
echocardiography. Cardiac magnetic resonance imaging
(CMR) is increasingly utilised for LVEF assessment, but
several studies have shown differences between LVEF
assessed by CMR and echocardiography. The present study
compared LVEF assessment by CMR and echocardiography
in a heart failure population and evaluated effects on eligibility
for device therapy.
Methods 152 patients (106 male, mean age 65.5±9.9 years)
referred for device therapy were included. During evaluation
of eligibility they underwent both CMR and echocardiograph-
ic LVEF assessment. CMR volumes were computed from a
stack of short-axis images. Echocardiographic volumes were
computed using Simpson’s biplane method.
Results The study population demonstrated an underestima-
tion of end-diastolic volume (EDV) and end-systolic volume
(ESV) by echocardiography of 71±53 ml (mean±SD) and 70
±49 ml, respectively. This resulted in an overestimation of
LVEF of 6.6±8.3 % by echocardiography compared with
CMR (echocardiographic LVEF 31.5±8.7 % and CMRLVEF
24.9±9.6 %). 28 % of patients had opposing outcomes of
eligibility for cardiac device therapy depending on the imag-
ing modality used.
Conclusion We found EDVand ESV to be underestimated by
echocardiography, and LVEF assessed by CMR to be signif-
icantly smaller than by echocardiography. Applying an LVEF
cut-off value of 35 %, CMR would significantly increase the
number of patients eligible for device implantation. Therefore,
LVEF cut-off values might need reassessment when using
CMR.
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Introduction
Cardiac resynchronisation therapy (CRT) and the implantable
cardioverter defibrillator (ICD) have substantially improved
the survival of heart failure patients.[1–4] A key criterion for
selection of CRT and ICD candidates is a severely depressed
left ventricular ejection fraction (LVEF). In daily clinical
practice, as well as in all large clinical trials, assessment of
LVEF is mainly performed by two-dimensional (2D) echocar-
diography due to its wide availability and guidelines do not
recommend a method for LVEF assessment.[1–4] Cardiac
magnetic resonance imaging (CMR) is considered the gold
standard to assess LVEF and is increasingly utilised for LVEF
assessment in routine clinical settings.[5–10] Several reports
have been published on the comparison between assessment
by 2D echocardiography and CMR.[5, 11–14] These studies
consistently reported a significant underestimation of both left
ventricular end-diastolic and systolic volumes by 2D echocar-
diography. On calculation of LVEF, however, conflicting re-
sults were found. The majority of these studies were per-
formed in patients with (near) normal LVEF and relatively
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small sample sizes were used. The consequences of these
differences between the two imaging modalities on ejection
fraction in heart failure patients and thus for eligibility for
cardiac device therapy are largely unknown, although there
are suggestions that CMR is preferable for LVEF assessment
in the case of selection for device implantation.[15, 16] The
present study compared LVEF assessed by 2D echocardiog-
raphy and CMR in a large group of heart failure patients who
were referred for evaluation of eligibility for device therapy
and the consequences for eligibility were evaluated.
Methods
Study population
Patients referred to the VU University Medical Center for
CRT and/or ICD implantation for primary prevention accord-
ing to current guidelines and who underwent both 2D echo-
cardiographic and CMR evaluation within 3 months prior to
implantation were included. A total of 152 patients with
chronic stable heart failure met these criteria. All patients were
under optimal medical therapy and there was no change in
medication or clinical condition between each assessment. All
analyses were done according to daily clinical practice and
both assessments are used regularly at our institution.
CMR image acquisition and analysis
CMR studies were performed on a 1.5-Tesla whole body
scanner (Magnetom Sonata/Avanto, Siemens, Erlangen, Ger-
many), using a six-channel phased-array body coil. After
survey scans, a retro-triggered, balanced steady-state free
precession gradient-echo sequence was used for cine imaging.
Image parameters included slice thickness of 5 mm, slice gap
5 mm, temporal resolution <50 ms, repetition time 3.2 ms,
echo time 1.54 ms, flip angle 60° and a typical image resolu-
tion of 1.3*1.6 mm. Stacks of 10–12 short-axis slices were
acquired to cover the left ventricle. Cine images were acquired
during breath-hold in mild expiration.
Images were analysed off-line, using the software package
MASS (MR Analytical Software System, Medis, Leiden, the
Netherlands). Endocardial borders of the left ventricle were
outlined manually in both the end-diastolic and end-systolic
phase in all short-axis images. Papillary muscles were includ-
ed in the left ventricular volume. End-diastolic volume
(EDV), end-systolic volume (ESV), and LVEF were comput-
ed using these analyses as previously described.[17]
Echocardiographic image acquisition and analysis
Two-dimensional echocardiographic images were obtained in
the standard parasternal long- and short-axis and apical four-
chamber and two-chamber views using commercially avail-
able ultrasound equipment. Three cardiac cycles were cap-
tured and no ultrasound contrast agents were used to enhance
image quality. Echocardiographic measurements were per-
formed offline from the apical windows by an expert reader
blinded to patient data. Left ventricular volumes and LVEF
were planimetred from the four-chamber and two-chamber
areas using the modified Simpson’s rule. Papillary muscles
were included in the left ventricular volumes and all measure-
ments were done in concordance with the American Society
of Echocardiography standards.[18]
Interobserver and intraobserver variability
Measurements of the left ventricular volumes were repeated in
15 subjects by the same observer and an experienced second
observer both blinded for previous measurements to assess
interobserver and intraobserver variability.
Statistical analysis
Continuous variables are presented asmean±SD, and categorical
data are summarised as frequencies and percentages. Compari-
sons between the imaging techniquesweremade using the Blant-
Altman analysis. A linear regression analysis was performed on
the Blant-Altman data to evaluate whether differences were
dependent of volumes. Intraobserver and interobserver variability
were assessed using the Blant-Altman analysis. A value of
p<0.05 was considered statistically significant. The statistical
analysis was performed bymeans of SPSS forWindows (version
16.0, SPSS Inc., Chicago, USA).
Results
A total of 152 patients with chronic stable heart failure were
included. The aetiology of heart failure was ischaemic cardio-
myopathy in 52 % and dilated cardiomyopathy in 48 % of
patients. Time between CMR and 2D echocardiography as-
sessment was a median of 7 days (interquartile range 0–35).
Baseline characteristics are depicted in Table 1.
Left ventricular volumes
EDVand ESV were found to be substantially smaller with 2D
echocardiography compared with CMR (Table 1, Fig. 1 panel
A and C). On average, 2D echocardiography significantly
underestimated EDV and ESV by 71±53 ml and 70±49 ml,
respectively. Stroke volumes, however, were comparable be-
tween the two techniques. Differences between the imaging
modalities increased significantly with increasing left ventric-
ular volumes for both EDV and ESV, as indicated by the
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regression lines in Fig. 1 (panel B and D), p<0.001 for both.
In contrast, the absolute difference (in ml) between echocar-
diographic and CMR assessment of EDV approximately
equalled the absolute difference (in ml) of ESV, independent
of volume. When comparing patients with ischaemic cardio-
myopathy and dilated cardiomyopathy, the differences in left
ventricular volumes between the two imaging modalities were
similar (EDV: 65±47 ml and 78±59 ml; ESV: 64±45 ml and
76±54 ml; respectively).
Mean LVEF assessed by CMR examination was 24.9±
9.6 % and the mean LVEF assessed by 2D echocardiography
was 31.5±8.7 %. Blant-Altman analysis showed a consistent
overestimation of the LVEF by 2D echocardiography com-
pared with CMR (6.6±8.3 %), with a trend to increase with
decreasing LVEF (p=0.161) (Fig. 2). The overestimation of
LVEF by 2D echocardiography was similar between the pa-
tients with ischaemic cardiomyopathy and those with dilated
cardiomyopathy (6.8±8.3 ml and 6.4±8.1 ml; respectively).
Interobserver and intraobserver variability
Analysis of intraobserver and interobserver variability of the
imaging modalities revealed a mean difference of 1.4±
7.6 % for the intraobserver variability of the 2D echo-
cardiographic LVEF and a mean difference of 1.5±
6.7 % for the interobserver variability of the 2D echo-
cardiographic LVEF. The mean difference for the
intraobserver variability of LVEF assessed by the CMR
was 0.3±2.7 % and the interobserver variability showed
a mean difference of 1.1±3.5 %.
Consequences for cardiac device eligibility
In the present study population, a significantly different pop-
ulation is selected for device therapy depending on the imag-
ing modality used (p<0.01) (Fig. 2), considering an LVEF
cut-off value of 35 %. A substantial proportion of patients
(28%) had opposing outcomes of eligibility for cardiac device
therapy depending on the imaging modality used (Table 2). Of
the patients, 6 % had an LVEF below 35 % with 2D echocar-
diography, but above 35 % with CMR and 22 % patients had
an LVEF above 35 % with 2D echocardiography, but below
35 % with CMR. In comparison, with 2D echocardiography,
24 additional patients (23 %) would be eligible for cardiac
device therapy using CMR.
Additional findings on CMR
A left ventricular thrombus was seen in 12 patients (7.9 %) by
CMR, while only 2 of them (1.3 %) were seen by echocardi-
ography. Therefore, a left ventricular thrombus was not iden-
tified by echocardiography in 10 patients (6.6 %).
Discussion
Present study shows that assessment of left ventricular volume
and LVEF by 2D echocardiography and CMR are not inter-
changeable in a heart failure population and that there is a
rather large discrepancy between the two methods. Two-
dimensional echocardiography underestimates the left ventric-
ular volumes and overestimates LVEF compared with CMR.
The underestimation of left ventricular volumes is larger when
these volumes are larger. Differences in LVEF tend to be
larger when the LVEF is smaller.
Left ventricular volumes
Several studies compared 2D echocardiography and CMR for
assessment of left ventricular volumes and LVEF.[5, 11–14]
These studies differ in number of included patients, aetiology
of heart disease and left ventricular function and volume, but
all consistently show underestimation of EDVand ESV by 2D
echocardiography compared with CMR. Reported mean dif-
ferences vary considerably between studies and range from 10
to 94 ml for ESV and from 11 to 131 for EDV.[5, 19] We
found the discrepancy between the two imaging modalities to
be strongly related to left ventricular volume, with increasing
differences in larger hearts. This finding is supported by a
smaller study by Gruszczynska et al. in ischaemic heart failure
patients.[13] It is further corroborated by the observation that
studies in hearts with predominantly (near) normal volumes
Table 1 Baseline characteristics
Baseline characteristics n=152
Age (years) 65.5±9.9
Male 107 (70 %)
Ischaemic cardiomyopathy 79 (52 %)
ACE-I 132 (87 %)
Beta-blocker 123 (81 %)
Diuretics 112 (74 %)
NYHA class I/II/III/IV 3/28/121/0 (2/18/80/0 %)
CMR EDV (ml) 283±96
CMR ESV (ml) 217±94
CMR SV (ml) 66±23
CMR EF (%) 24.9±9.6
2D echocardiographic EDV (ml) 213±74
2D echocardiographic ESV (ml) 149±65
2D echocardiographic SV (ml) 64±22
2D echocardiographic EF (%) 31.5±8.7
CMR cardiac magnetic resonance imaging, EF ejection fraction, EDV
end-diastolic volume, ESV end-systolic volume, SV stroke volume
Neth Heart J (2014) 22:449–455 451
report lower differences, whereas studies including dilated
hearts are at the higher end of the spectrum.[5, 11, 14, 20]
The underestimation of left ventricular volumes in 2D echo-
cardiography compared with CMR might be explained by two
major factors. Firstly, CMR analysis includes the
trabecularisation in the left ventricular cavity, whereas 2D echo-
cardiography does this to a lesser extent. Secondly, in 2D echo-
cardiography both suboptimal transducer position causing
Fig. 2 LVEF assessed by 2D echocardiographic and CMR with linear
regression line and lines indicating the LVEF cut-off of 35 %, according
to the guidelines (a). Blant-Altman analysis LVEF by 2D
echocardiography and CMR, including linear regression line (b). The
thick line indicates the mean difference. CMR: cardiac magnetic reso-
nance imaging; and LVEF: left ventricular ejection fraction
Fig. 1 2D echocardiographic and CMR measurements with linear re-
gression line (dotted line) for EDV (a) and ESV (c). Blant-Altman
analysis of EDV (b) and ESV (d) assessed by 2D echocardiography
and CMR, including linear regression line (dotted line). The thick line
indicates the mean differenced. CMR: cardiac magnetic resonance imag-
ing; EDV: end-diastolic volume; and ESV: end-systolic volume
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foreshortening and gain-dependent edge identification might
cause volume underestimation. Several other factors might add
to the discrepancy. CMR uses the summation of disks method.
At the basal level, the short-axis image typically transects the
mitral valve plane and as a consequence the left ventricular cavity
might be difficult to determine exactly. On the other hand,
Simpson’s biplanemethod used in 2D echocardiography volume
assessment makes geometric assumptions which might not hold
true in case of regional deformation, which is present in a
substantial number of heart failure patients. These regional de-
formations are more often seen in patients with ischaemic car-
diomyopathy, but the current study did not demonstrate a differ-
ence between patients with ischaemic cardiomyopathy and pa-
tients with dilated cardiomyopathy.
Left ventricular ejection fraction
Studies on differences in LVEF assessed by the two imaging
techniques reported contradictory results, from an overestimation
of 7 % to an underestimation of 4 % by 2D echocardiography
compared with CMR.[11, 12] Only two previous studies focused
on patients with a severely depressed ejection fraction. In a small
study (n=36) Bellenger et al. found no significant difference, but a
larger (n=67) more recent study in an ischaemic cardiomyopathy
population with low ejection fraction showed an LVEF overesti-
mation of 5.7 % by echocardiography.[5, 13] Our results closely
resemble those of Gruszczynska et al. in a larger study population
including non-ischaemic cardiomyopathy patients as well.
The inconsistencies among studies in reported differences of
LVEF assessment might in part be attributable to differences in
study population. From a theoretical point of view, systematic
underestimation to a similar extent in EDVand ESV by echo, as
observed in several studies including the present one, will result
in overestimation of LVEF. This notion is supported by the
trend of increasing discrepancy with decreasing LVEF, found in
both our study and that of Gruszczynska et al.[13] Moreover, in
a study including a wider range of LVEF, Duncan et al. reported
a significantly larger echocardiographic overestimation of
LVEF with lower LVEF.[21]
LVEF assessment by CMR is generally considered the
golden standard. However, data on intraobserver and interob-
server variability of LVEF assessed by CMR and 2D echo-
cardiography in heart failure patients are scarce. Some reports
show a small increase in observer variability for heart failure
patients compared with normal subjects.[22, 23] The present
study demonstrated superior intraobserver and interobserver
variability of LVEF assessment for CMR compared with 2D
echocardiography, comparable with previous studies.[20–22]
Additional CMR and echocardiography parameters
Left ventricular thrombus is one of the additional findings which
can been shown by CMR. In the current study 7.9 % of patients
had a left ventricular thrombus on CMR, which is comparable
with earlier studies.[15] Conventional echocardiography only
discovered 1.3 % of the left ventricular thrombi, which is in line
with the known low sensitivity of thrombus detection by
echocardiography.[24] Most of these left ventricular thrombi
are probably not clinically relevant, as the rate of embolisation
is thought to be low.[25] However, testing of the defibrillation
threshold might be avoided in patients with a left ventricular
thrombus, because of the supposed risk of embolisation.
In echocardiography the development of 3D imaging has
been interesting. Meta-analysis of multiple studies has shown
good correlations between left ventricular volumes assessed
by 3D echocardiography and CMR.[26] Although 3D echo-
cardiography underestimates the volumes, LVEF measure-
ments are similar to the measurements obtained by
CMR.[26] Moreover, the same results between 3D echocar-
diography and CMR have been seen in heart failure
patients.[27] Therefore, 3D echocardiography might be an
appropriate alternative instead of CMR in the assessment of
LVEF in patients eligible for device therapy.
In the evaluation for ICD implantation, the LVEF is currently
the most important imaging parameter. In the evaluation for CRT
the assessment of left ventricular dyssynchrony is an additional
aspect next to the LVEF, which can be assessed by both CMR
and echocardiography. CMR tagging is capable of measuring
dyssynchrony and predicting response.[28] Tissue Doppler im-
aging and speckle tracking are echocardiographic techniques to
assess left ventricular dyssynchrony. Both techniques can predict
response to CRT.[29, 30] The assessment of left ventricular
dyssynchrony has not yet been incorporated in the guidelines
for CRT, but in individual patients it can be of importance.
Consequences for cardiac device eligibility
The observed differences in assessment of LVEF between the
two imaging modalities have significant clinical consequences.
Applying the 35 % cut-off value, eligibility for cardiac device
therapy will largely depend on the imaging modality used. A
substantial proportion of patients (28 %) had opposing outcomes
of eligibility for cardiac device therapy when their LVEF was
assessed with CMR compared with echocardiography. This was
previously shown in two smaller studies that demonstrated that a
significant proportion of patients (21 %) were reclassified ac-
cording to the imaging modality.[15, 16]
Table 2 Eligibility for cardiac device therapy according to imagingmodality
CMR EF>35 % CMR EF≤35 % Total
Echo EF>35 % 14 (9 %) 33 (22 %) 47 (31 %)
Echo EF≤35 % 9 (6 %) 96 (63 %) 105 (69 %)
Total 23 (15 %) 129 (85 %) 152 (100 %)
EF ejection fraction, CMR cardiac magnetic resonance imaging
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Furthermore, in comparison with 2D echocardiography 23 %
more patients would be eligible for cardiac device therapy when
using LVEF assessed by CMR. This increase in the number of
eligible patients was also established in previous research.[15]
This rise in eligible patients questions whether one should use the
same cut-off value in 2D echocardiography and CMR. A lower
cut-off value for LVEF assessed by CMR might be more appro-
priate in order to select patients most at risk for ventricular
arrhythmias; however it could also be assumed that a higher
cut-off for 2D echocardiography should be used.
One study has evaluated the impact of CMR-assessed
LVEF on ICD therapy up till now.[16] It showed that LVEF
assessed by CMR was a better predictor of device therapy
compared with LVEF assessed by 2D echocardiography.
However, larger studies should reveal the actual impact of
CMR and eligibility for device therapy.
Limitations
Assessments by CMR and echocardiography were not per-
formed simultaneously in the small subset of patients and
ultrasound contrast was not used to enhance endocardial con-
tours in any of the patients. Although patients were clinically
stable between the two assessments, subclinical changes
might have occurred in their condition affecting study out-
come. Furthermore, the study was conducted retrospectively
and only patients who were referred for device therapy were
analysed, which might have introduced a selection bias. How-
ever, since this study describes a straightforward comparison
of imaging data and not patient outcome, a selection bias is of
lesser relevance. Another bias was probably introduced by the
echocardiographic image quality. In the current study all pa-
tients had a moderate to good echocardiographic image qual-
ity and all images were sufficient for volume assessment.
Therefore, patients with poor echocardiographic image qual-
ity might not be subject to echocardiography prior to the CMR
assessment, because of their known poor image quality.
Conclusion
In conclusion, this study showed a systematic overestimation of
LVEF assessed by 2D echocardiography comparedwith CMR in
heart failure patients with a severely depressed LVEF. This
implies that the two imaging modalities are not interchangeable
in this patient population. The discrepancy may significantly
impact clinical decisions for individual patients, for example
eligibility for device therapy. As CMR has better observer vari-
ability, it would be the preferred method for LVEF assessment in
heart failure patients. However, LVEFs assessed by CMR are
consistently smaller than those assessed by 2D echocardiogra-
phy. The present study and previous work point towards the
necessity for resetting cut-off values when CMR is used for
LVEF assessment. Future studies should address this necessity
and should evaluate whether LVEF assessed by CMR improves
prediction of beneficial effects of device therapy compared with
echocardiographic evaluation.
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